Biodegradation and reversible inhibitory impact of sulfamethoxazole on the utilization of volatile fatty acids during anaerobic treatment of pharmaceutical industry wastewater
- 1 December 2015
- journal article
- Published by Elsevier in Science of The Total Environment
- Vol. 536, 667-674
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effects on activated sludge bacterial community exposed to sulfamethoxazoleChemosphere, 2013
- Acute inhibitory impact of antimicrobials on acetoclastic methanogenic activityBioresource Technology, 2012
- Sorption and biodegradation of sulfonamide antibiotics by activated sludge: Experimental assessment using batch data obtained under aerobic conditionsWater Research, 2011
- Occurrence of pharmaceuticals and hormones in sewage sludgeEnvironmental Toxicology and Chemistry, 2010
- Methanogenic population dynamics during semi‐continuous biogas fermentation and acidification by overloadingJournal of Applied Microbiology, 2010
- Phylogenetic Comparison of the Methanogenic Communities from an Acidic, Oligotrophic Fen and an Anaerobic Digester Treating Municipal Wastewater SludgeApplied and Environmental Microbiology, 2008
- Treatability of sulfamerazine in sequential upflow anaerobic sludge blanket reactor (UASB)/completely stirred tank reactor (CSTR) processesSeparation and Purification Technology, 2007
- Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification schemeWater Research, 2006
- Performance of an up-flow anaerobic stage reactor (UASR) in the treatment of pharmaceutical wastewater containing macrolide antibioticsWater Research, 2006
- On the occasional biodegradation of pharmaceuticals in the activated sludge process: The example of the antibiotic sulfamethoxazoleJournal of Hazardous Materials, 2005